Topic: COVAXIN
EUA to Corbevax for 12-18 Age Group
A vaccine manufacturer based in Hyderabad, Biological E has received emergency use authorization (EUA) from the drug regulator of India for its Covid-19 vaccine for children aged 12...
Bharat Biotech Nasal Booster Trials
The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are... Conditional market approval for Covaxin, Covishield
The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the...
Commemorative Postal Stamp on COVID-19 vaccine
The Ministry of Health and Family Welfare recently released commemorative postal stamp on COVID-19 vaccine. The stamp was launched to mark the first anniversary of the National COVID... Precautionary vaccine jabs in India
The Government of India is to provide third dose of vaccine. This third dose has been named “precaution dose” or booster dose. About the precaution dose The health... India set to touch 100 crore Covid vaccination mark
India crossed another significant milestone in its fight against the covid-19 pandemic on October 21, 2021. It touched the mark of 100 crore Covid vaccinations including the first...
Covishield-jabbed to be allowed into 8 European countries
Eight European Union states included Covishield in list of vaccines approved to enter into the region. Key Points Covishield was allowed in 8 EU counties after India warned... ZyCoV-D: World’s first DNA-based Vaccine
Indian pharmaceutical company Zydus Cadila is soon going to apply Central Drugs Regulator (DGCI) for emergency approval of the corona vaccine ZyCoV-D. If approved, it will be the... Vaccine Prices capped for Private Hospitals
Union Health Ministry has capped the price for administration of Covid-19 vaccines in private hospitals. Key Points Maximum price for Covaxin was fixed at Rs 1,400. Covishield will...
COVISHIELD: Gap between doses increased
The Government of India recently increased the gap between the two doses of the COVISHIELD Vaccine. The gap was increased from six to eight weeks to twelve to...
Sinopharm Vaccine approved by WHO
The World Health Organisation recently approved the Emergency Use of Sinpharm vaccine. Recently, the WHO approved COVID-19 vaccines developed by AstraZeneca, Pfizer, BioNTech, Johnson and Johnson as well....
